Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon
暂无分享,去创建一个
David E. Williams | G. Johnson | E. Ho | C. Löhr | Masayuki Yamamoto | R. Dashwood | W. Dashwood | P. Rajendran | K. Fischer | Yu-hua Kang | Eunah Kim | Li Li | D. Lieberman
[1] David E. Williams,et al. Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract. , 2015, Molecular nutrition & food research.
[2] A. Kong,et al. Nrf2 knockout enhances intestinal tumorigenesis in Apcmin/+ mice due to attenuation of anti‐oxidative stress pathway while potentiates inflammation , 2014, Molecular carcinogenesis.
[3] Ø. Bruserud,et al. Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents , 2013, Clinical Epigenetics.
[4] Masayuki Yamamoto,et al. Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. , 2013, Cancer research.
[5] David E. Williams,et al. HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates , 2013, Epigenetics.
[6] Mary Goldman,et al. The UCSC Genome Browser database: extensions and updates 2013 , 2012, Nucleic Acids Res..
[7] Tao Chen,et al. Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. , 2013, Topics in current chemistry.
[8] David E. Williams,et al. A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis , 2012, Clinical Epigenetics.
[9] M. Sporn,et al. NRF2 and cancer: the good, the bad and the importance of context , 2012, Nature Reviews Cancer.
[10] J. Davie,et al. Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors , 2012, Clinical Epigenetics.
[11] Yuan-Xiang Pan,et al. Histone deacetylase 3 (HDAC3) participates in the transcriptional repression of the p16INK4a gene in mammary gland of the female rat offspring exposed to an early-life high-fat diet , 2012, Epigenetics.
[12] Mary Goldman,et al. The UCSC Genome Browser database: extensions and updates 2011 , 2011, Nucleic Acids Res..
[13] Chun-Yin Huang,et al. The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression , 2011, Nucleic acids research.
[14] David E. Williams,et al. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells , 2011, Clinical Epigenetics.
[15] David E. Williams,et al. Metabolism and Tissue Distribution of Sulforaphane in Nrf2 Knockout and Wild-Type Mice , 2011, Pharmaceutical Research.
[16] C. Löhr,et al. NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP) , 2011, International journal of cancer.
[17] David E. Williams,et al. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly , 2011, Molecular Cancer.
[18] David E. Williams,et al. Metabolism as a key to histone deacetylase inhibition , 2011, Critical reviews in biochemistry and molecular biology.
[19] A. Mazo,et al. p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors , 2011, Oncogene.
[20] Min Chen,et al. Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A. , 2010, International journal of oncology.
[21] M. Nagino,et al. Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma , 2010, Cancer science.
[22] S. Henikoff,et al. Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model , 2010, Molecular carcinogenesis.
[23] T. Kensler,et al. Nrf2: friend or foe for chemoprevention? , 2010, Carcinogenesis.
[24] R. Tuma. Epigenetic therapies move into new territory, but how exactly do they work? , 2009, Journal of the National Cancer Institute.
[25] Shan Zhu,et al. The transcription factor ZBP‐89 suppresses p16 expression through a histone modification mechanism to affect cell senescence , 2009, The FEBS journal.
[26] W-S Xu,et al. Histone deacetylase inhibitors: Potential in cancer therapy , 2009, Journal of cellular biochemistry.
[27] Xiuli Wang,et al. YY1 restrained cell senescence through repressing the transcription of p16. , 2008, Biochimica et biophysica acta.
[28] B. Delage,et al. Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter. , 2008, Carcinogenesis.
[29] A. Kong,et al. Increased Susceptibility of Nrf2 Knockout Mice to Colitis-Associated Colorectal Cancer , 2008, Cancer Prevention Research.
[30] H. Lehr,et al. Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice , 2008, Gut.
[31] Masayuki Yamamoto,et al. Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2‐deficient mice upon dextran sulfate treatment , 2007, International journal of cancer.
[32] C. Rock,et al. Increase in Cruciferous Vegetable Intake in Women Previously Treated for Breast Cancer Participating in a Dietary Intervention Trial , 2007, Nutrition and cancer.
[33] E. Ho,et al. Sulforaphane Retards the Growth of Human PC-3 Xenografts and Inhibits HDAC Activity in Human Subjects , 2007, Experimental biology and medicine.
[34] A. Valentini,et al. Valproic acid induces apoptosis, p16INK4A upregulation and sensitization to chemotherapy in human melanoma cells , 2007, Cancer biology & therapy.
[35] A. Kong,et al. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. , 2006, Cancer research.
[36] G. Mack. Epigenetic cancer therapy makes headway. , 2006, Journal of the National Cancer Institute.
[37] M. Ffrench,et al. Régulation de p16INK4a, sénescence et oncogenèse , 2006 .
[38] A. Kong,et al. Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. , 2006, Carcinogenesis.
[39] Andrew J. Wilson,et al. Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer* , 2006, Journal of Biological Chemistry.
[40] E. Ho,et al. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apcmin mice , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] R. Dashwood,et al. Chemoprotection by sulforaphane: keep one eye beyond Keap1. , 2006, Cancer letters.
[42] E. Ho,et al. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? , 2006, Carcinogenesis.
[43] M. Ffrench,et al. [Regulation of p16INK4a, senescence and oncogenesis]. , 2006, Medecine sciences : M/S.
[44] F. Pierre,et al. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. , 2005, European journal of cancer.
[45] P. Karplus,et al. A Novel Mechanism of Chemoprotection by Sulforaphane , 2004, Cancer Research.
[46] P. Pandolfi,et al. The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia , 2002, Nature Medicine.
[47] G. Peters,et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence , 2001, Nature.
[48] C. Rao,et al. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. , 2000, Carcinogenesis.
[49] P. Nambiar,et al. Differential Expression of p16INK4a in Azoxymethane‐Induced Mouse Colon Tumorigenesis , 2000, Molecular carcinogenesis.
[50] J. Fahey,et al. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] C. Cho,et al. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Wargovich,et al. Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds. , 1990, Cancer research.